Location: Tel Aviv, Israel
CIK: 0001496201 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 14, 2020
Total Value: $800M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IWM | ISHARES TR | 900,000 | $103M | 12.9% | — | — | Put | 464287655 |
| MRK | MERCK & CO. INC | 868,518 | $66.82M | 8.4% | $56.19 | +15.8% | COM | 58933Y105 |
| SPY | SPDR S&P 500 ETF TR | 209,900 | $54.1M | 6.8% | — | — | Put | 78462F103 |
| JNJ | JOHNSON & JOHNSON | 348,653 | $45.72M | 5.7% | $112.04 | +7.2% | COM | 478160104 |
| BMY | BRISTOL-MYERS SQUIBB CO | 780,000 | $43.48M | 5.4% | $41.42 | +17.3% | COM | 110122108 |
| SNY | SANOFI | 970,000 | $42.41M | 5.3% | $47.82 | — | SPONSORED ADR | 80105N105 |
| XBI | SPDR SER TR | 500,000 | $38.72M | 4.8% | — | — | Put | 78464A870 |
| NVO | NOVO-NORDISK A S | 576,000 | $34.67M | 4.3% | $53.53 | — | ADR | 670100205 |
| AZN | ASTRAZENECA PLC | 570,000 | $25.46M | 3.2% | $44.66 | — | SPONSORED ADR | 046353108 |
| SRPT | SAREPTA THERAPEUTICS INC | 258,000 | $25.24M | 3.2% | $111.14 | +2.9% | COM | 803607100 |
| — | ALEXION PHARMACEUTICALS INC | 249,396 | $22.39M | 2.8% | $106.35 | — | COM | 015351109 |
| FOLD | AMICUS THERAPEUTICS INC | 2,017,624 | $18.64M | 2.3% | $12.38 | -23.2% | COM | 03152W109 |
| PFE | PFIZER INC | 550,000 | $17.95M | 2.2% | $25.83 | 0.0% | COM | 717081103 |
| MSFT | MICROSOFT CORP | 93,964 | $14.82M | 1.9% | $116.89 | +33.8% | COM | 594918104 |
| ABBV | ABBVIE INC | 165,000 | $12.57M | 1.6% | $67.19 | 0.0% | COM | 00287Y109 |
| NVS | NOVARTIS A G | 140,000 | $11.54M | 1.4% | $94.69 | — | SPONSORED ADR | 66987V109 |
| — | KARYOPHARM THERAPEUTICS INC | 550,000 | $10.57M | 1.3% | $19.19 | — | COM | 48576U106 |
| AMZN | AMAZON COM INC | 5,270 | $10.28M | 1.3% | $89.95 | +7.6% | COM | 023135106 |
| QURE | UNIQURE NV | 201,107 | $9.543M | 1.2% | $50.17 | +14.5% | SHS | N90064101 |
| — | CONCERT PHARMACEUTICALS INC | 1,013,039 | $8.955M | 1.1% | $8.43 | — | COM | 206022105 |
| — | X4 PHARMACEUTICALS INC | 873,215 | $8.732M | 1.1% | $10.81 | — | COM | 98420X103 |
| ALLT | ALLOT LTD | 915,302 | $8.65M | 1.1% | $7.06 | +41.6% | SHS | M0854Q105 |
| — | Y-MABS THERAPEUTICS INC | 307,379 | $8.023M | 1.0% | $24.49 | — | COM | 984241109 |
| XLP | SELECT SECTOR SPDR TR | 145,207 | $7.909M | 1.0% | $54.47 | — | SBI CONS STPLS | 81369Y308 |
| — | ZYMEWORKS INC | 206,830 | $7.336M | 0.9% | $27.37 | — | COM | 98985W102 |
| — | AXOVANT GENE THERAPIES LTD | 2,931,018 | $7.152M | 0.9% | $2.96 | — | COM | G0750W203 |
| — | PASSAGE BIO INC | 478,171 | $7.135M | 0.9% | $14.92 | — | COM | 702712100 |
| ACAD | ACADIA PHARMACEUTICALS INC | 157,000 | $6.633M | 0.8% | $40.18 | +2.5% | COM | 004225108 |
| — | BLUEPRINT MEDICINES CORP | 109,500 | $6.404M | 0.8% | $76.84 | — | COM | 09627Y109 |
| ARVN | ARVINAS INC | 145,781 | $5.875M | 0.7% | $16.55 | +182.5% | COM | 04335A105 |
| ADMA | ADMA BIOLOGICS INC | 1,838,100 | $5.294M | 0.7% | $3.72 | -7.1% | COM | 000899104 |
| CRM | SALESFORCE COM INC | 35,529 | $5.115M | 0.6% | $169.39 | 0.0% | COM | 79466L302 |
| — | TRILLIUM THERAPEUTICS INC | 1,260,694 | $5.093M | 0.6% | $4.04 | — | COM NEW | 89620X506 |
| AUDC | AUDIOCODES LTD | 206,619 | $4.936M | 0.6% | $12.22 | +62.7% | ORD | M15342104 |
| — | DECIPHERA PHARMACEUTICALS IN | 119,500 | $4.92M | 0.6% | $41.17 | — | COM | 24344T101 |
| — | EXICURE INC | 3,284,795 | $4.861M | 0.6% | $2.43 | — | COM | 30205M101 |
| BEAM | BEAM THERAPEUTICS INC | 264,681 | $4.764M | 0.6% | $21.73 | 0.0% | COM | 07373V105 |
| RCKT | ROCKET PHARMACEUTICALS INC | 335,016 | $4.673M | 0.6% | $14.40 | +37.5% | COM | 77313F106 |
| GRTX | GALERA THERAPEUTICS INC | 475,677 | $4.519M | 0.6% | $12.19 | +5.7% | COM | 36338D108 |
| — | NEOLEUKIN THERAPEUTICS INC | 397,000 | $4.518M | 0.6% | $12.28 | — | COM | 64049K104 |
| — | ORGENESIS INC | 1,109,564 | $4.216M | 0.5% | $3.80 | — | COM NEW | 68619K204 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 526,075 | $3.714M | 0.5% | $9.93 | -24.5% | COM | 74366E102 |
| ASND | ASCENDIS PHARMA A S | 32,573 | $3.668M | 0.5% | $43.10 | — | SPONSORED ADR | 04351P101 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 356,713 | $3.203M | 0.4% | $8.53 | — | SPONSORED ADS | 881624209 |
| — | PROTEOSTASIS THERAPEUTICS IN | 2,536,600 | $2.892M | 0.4% | $2.28 | — | COM | 74373B109 |
| VKTX | VIKING THERAPEUTICS INC | 590,000 | $2.761M | 0.3% | $7.29 | -15.7% | COM | 92686J106 |
| PANW | PALO ALTO NETWORKS INC | 16,452 | $2.697M | 0.3% | $32.77 | +6.5% | COM | 697435105 |
| ALDX | ALDEYRA THERAPEUTICS INC | 1,069,089 | $2.641M | 0.3% | $6.86 | -34.4% | COM | 01438T106 |
| FVRR | FIVERR INTL LTD | 104,839 | $2.639M | 0.3% | $24.86 | +8.2% | ORD SHS | M4R82T106 |
| SAVA | CASSAVA SCIENCES INC | 615,000 | $2.528M | 0.3% | $6.62 | 0.0% | COM | 14817C107 |
| — | ZAFGEN INC | 3,161,562 | $2.434M | 0.3% | $0.81 | — | COM | 98885E103 |
| EOLS | EVOLUS INC | 550,000 | $2.283M | 0.3% | $10.01 | -15.3% | COM | 30052C107 |
| — | ARYA SCIENCES ACQUISITION CO | 200,000 | $2.258M | 0.3% | $10.69 | — | UNIT 10/04/2023 | G3165V117 |
| — | APPLIED THERAPEUTICS INC | 67,967 | $2.222M | 0.3% | $32.69 | — | COM | 03828A101 |
| PRQR | PROQR THRAPEUTICS N V | 346,148 | $1.9M | 0.2% | $8.46 | -9.3% | SHS EURO | N71542109 |
| — | NEOS THERAPEUTICS INC | 2,509,468 | $1.882M | 0.2% | $2.56 | — | COM | 64052L106 |
| KALV | KALVISTA PHARMACEUTICALS INC | 240,140 | $1.837M | 0.2% | $13.22 | +2.1% | COM | 483497103 |
| VRTX | VERTEX PHARMACEUTICALS INC | 7,000 | $1.666M | 0.2% | $229.39 | 0.0% | COM | 92532F100 |
| — | IMMUNOVANT INC | 94,500 | $1.564M | 0.2% | $24.87 | — | UNIT 12/18/2024 | 45258J201 |
| ARGX | ARGENX SE | 10,265 | $1.352M | 0.2% | $84.36 | — | SPONSORED ADR | 04016X101 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 24,752 | $1.265M | 0.2% | $51.11 | — | COM | 37890U108 |
| — | MINERVA NEUROSCIENCES INC | 168,357 | $1.014M | 0.1% | $7.74 | — | COM | 603380106 |
| — | LEAP THERAPEUTICS INC | 600,000 | $948K | 0.1% | $1.58 | — | COM | 52187K101 |
| — | APTINYX INC | 411,666 | $889K | 0.1% | $2.16 | — | COM | 03836N103 |
| — | PRECISION BIOSCIENCES INC | 147,352 | $889K | 0.1% | $15.26 | — | COM | 74019P108 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 68,134 | $747K | 0.1% | $9.38 | 0.0% | COM | 87164F105 |
| — | ALLENA PHARMACEUTICALS INC | 667,800 | $643K | 0.1% | $6.05 | — | COM | 018119107 |
| STOK | STOKE THERAPEUTICS INC | 27,254 | $624K | 0.1% | $26.85 | -8.0% | COM | 86150R107 |
| — | NICE SYS INC | 250,000 | $445K | 0.1% | $1.78 | — | NOTE 1.250% 1/1 | 65366HAB9 |
| — | IVERIC BIO INC | 123,424 | $425K | 0.1% | $8.58 | — | COM | 46583P102 |
| — | ZYNERBA PHARMACEUTICALS INC | 100,000 | $383K | 0.0% | $3.83 | — | COM | 98986X109 |
| — | CYCLERION THERAPEUTICS INC | 124,976 | $331K | 0.0% | $2.65 | — | COM | 23255M105 |
| — | SUNESIS PHARMACEUTICALS INC | 721,800 | $299K | 0.0% | $0.72 | — | COM | 867328700 |
| IMVT | IMMUNOVANT INC | 19,032 | $296K | 0.0% | $11.17 | +34.7% | COM | 45258J102 |
| — | BRISTOL-MYERS SQUIBB CO | 50,000 | $190K | 0.0% | $3.80 | — | RIGHT 99/99/9999 | 110122157 |
| — | OUTLOOK THERAPEUTICS INC | 129,500 | $130K | 0.0% | $1.00 | — | *W EXP 02/18/202 | 69012T115 |
| MIST | MILESTONE PHARMACEUTICALS IN | 67,992 | $125K | 0.0% | $17.31 | 0.0% | COM | 59935V107 |
| — | CELLECTAR BIOSCIENCES INC | 87,500 | $111K | 0.0% | $3.01 | — | COM PAR | 15117F500 |